The main new findings of the current study were that Dap treatment reduced the membrane gp91phox and p22phox expression and restrained translocation of the p67phox subunit to the membrane fraction both in STZ-induced DCM rats and H9C2 cells exposed to high glucose. The gene discussed is NCF2; the disease is familial dilated cardiomyopathy.